• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First Experience With Extracorporeal Cytokine Adsorption Therapy After Lung Transplantation.

作者信息

Peyneau Marine, de Chaisemartin Luc, Faille Dorothée, Messika Jonathan, Mal Hervé, Castier Yves, Mordant Pierre, Carrasco José Luis, Tanaka Sébastien, Lortat Jacob Brice, Ferrari Paola, Arrault Xavier, Ajzenberg Nadine, Chollet-Martin Sylvie, Montravers Philippe, Tran-Dinh Alexy

机构信息

Autoimmunity and Hypersensitivity Laboratory, AP-HP, Hôpital Bichat-Claude-Bernard, Paris, France.

Faculty of Pharmacy, INSERM UMR 996, Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Châtenay-Malabry, France.

出版信息

Transpl Int. 2022 Mar 21;35:10319. doi: 10.3389/ti.2022.10319. eCollection 2022.

DOI:10.3389/ti.2022.10319
PMID:35387399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8977406/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ef/8977406/95d3d98055fd/ti-35-10319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ef/8977406/95d3d98055fd/ti-35-10319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ef/8977406/95d3d98055fd/ti-35-10319-g001.jpg

相似文献

1
First Experience With Extracorporeal Cytokine Adsorption Therapy After Lung Transplantation.肺移植后体外细胞因子吸附疗法的首次经验
Transpl Int. 2022 Mar 21;35:10319. doi: 10.3389/ti.2022.10319. eCollection 2022.
2
Hemoadsorption treatment with CytoSorb in patients with extracorporeal life support therapy: A case series.细胞吸附剂（CytoSorb）用于体外生命支持治疗患者的血液吸附治疗：病例系列
Int J Artif Organs. 2020 Jun;43(6):422-429. doi: 10.1177/0391398819895287. Epub 2019 Dec 23.
3
Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO.体外膜肺氧合（ECMO）期间使用CytoSorb进行体外血液吸附的机遇、争议与挑战。
Artif Organs. 2021 Oct;45(10):1240-1249. doi: 10.1111/aor.14025. Epub 2021 Aug 8.
4
Extracorporeal membrane oxygenation and cytokine adsorption.体外膜肺氧合与细胞因子吸附
J Thorac Dis. 2018 Mar;10(Suppl 5):S653-S660. doi: 10.21037/jtd.2017.10.128.
5
Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.严重 COVID-19 合并相关器官衰竭患者接受 CRRT 或 ECMO 治疗时的辅助血液吸附治疗：一项病例系列研究。
Int J Artif Organs. 2021 Oct;44(10):694-702. doi: 10.1177/03913988211030517. Epub 2021 Jul 13.
6
Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb) in the management of septic shock: A retrospective observational study.体外细胞因子吸附疗法（CytoSorb）血液吸附治疗感染性休克：一项回顾性观察研究。
Int J Artif Organs. 2020 Jun;43(6):372-378. doi: 10.1177/0391398819891739. Epub 2019 Dec 23.
7
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.严重新型冠状病毒肺炎需体外膜肺氧合治疗患者的细胞因子吸附（CYCOV）：一项单中心、开放标签、随机对照试验
Lancet Respir Med. 2021 Jul;9(7):755-762. doi: 10.1016/S2213-2600(21)00177-6. Epub 2021 May 14.
8
Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study.脓毒性休克的细胞外细胞因子吸附：概念验证随机对照初步研究。
J Crit Care. 2019 Feb;49:172-178. doi: 10.1016/j.jcrc.2018.11.003. Epub 2018 Nov 10.
9
Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis.细胞吸附柱（CytoSorb）与体外膜肺氧合（ECMO）联合用于重症肺炎性脓毒症患者
Thorac Cardiovasc Surg. 2021 Apr;69(3):246-251. doi: 10.1055/s-0040-1708479. Epub 2020 Apr 6.
10
Central Extracorporeal Membrane Oxygenation for Bridging of Right-Sided Heart Failure to Lung Transplantation: A Single-Center Experience and Literature Review.右侧心力衰竭到肺移植桥接的中心体外膜氧合：单中心经验和文献复习。
J Cardiothorac Vasc Anesth. 2019 Jul;33(7):1873-1876. doi: 10.1053/j.jvca.2019.01.059. Epub 2019 Feb 8.

引用本文的文献

1
From critical care to organ preservation: the potential role of hemadsorption in transplantation-a narrative review.从重症监护到器官保存：血液吸附在移植中的潜在作用——一篇叙述性综述
Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):608-629. doi: 10.21037/hbsn-24-446. Epub 2025 Apr 15.
2
Mitigating the risk of inflammatory type primary graft dysfunction by applying an integrated approach to assess, modify and match risk factors in lung transplantation.通过采用综合方法评估、调整和匹配肺移植中的风险因素，降低炎症性原发性移植物功能障碍的风险。
Front Transplant. 2024 Aug 20;3:1422088. doi: 10.3389/frtra.2024.1422088. eCollection 2024.
3

本文引用的文献

1
Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial.体外细胞因子清除治疗脓毒性休克的剂量研究（DECRISS）：一项前瞻性、随机、适应性、多中心临床试验方案。
BMJ Open. 2021 Aug 26;11(8):e050464. doi: 10.1136/bmjopen-2021-050464.
2
The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock.体外细胞因子清除在高炎症性休克血流动力学稳定中的潜在作用
Biomedicines. 2021 Jul 1;9(7):768. doi: 10.3390/biomedicines9070768.
3
Hemoadsorption by CytoSorb in septic patients: a case series.
Hemoadsorption in Organ Preservation and Transplantation: A Narrative Review.
血液吸附在器官保存与移植中的应用：一篇叙述性综述
Life (Basel). 2023 Dec 29;14(1):65. doi: 10.3390/life14010065.
4
Design and Rationale of Cytokine Filtration in Lung Transplantation (GLUSorb): Protocol for a Multicenter Clinical Randomized Controlled Trial.肺移植中细胞因子过滤的设计与原理（GLUSorb）：一项多中心临床随机对照试验方案
JMIR Res Protoc. 2023 Dec 13;12:e52553. doi: 10.2196/52553.
5
Extracorporeal cytokine adsorption reduces systemic cytokine storm and improves graft function in lung transplantation.体外细胞因子吸附可减轻肺移植中的全身细胞因子风暴并改善移植物功能。
JTCVS Open. 2023 Jul 4;15:497-507. doi: 10.1016/j.xjon.2023.06.011. eCollection 2023 Sep.
6
Use of CytoSorb© Hemoadsorption in Patients on Veno-Venous ECMO Support for Severe Acute Respiratory Distress Syndrome: A Systematic Review.细胞吸附柱（CytoSorb©）血液吸附在接受静脉-静脉体外膜肺氧合（Veno-Venous ECMO）支持的重症急性呼吸窘迫综合征患者中的应用：一项系统评价
J Clin Med. 2022 Oct 11;11(20):5990. doi: 10.3390/jcm11205990.
细胞吸附剂（CytoSorb）对脓毒症患者的血液吸附：病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
4
Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series.血液吸附治疗体外循环后全身炎症反应综合征：病例系列
Int J Artif Organs. 2016 May 16;39(3):141-6. doi: 10.5301/ijao.5000492. Epub 2016 Apr 25.
5
First report of cytokine removal using CytoSorb® in severe noninfectious inflammatory syndrome after liver transplantation.使用CytoSorb®清除肝移植后严重非感染性炎症综合征中细胞因子的首例报告。
Int J Artif Organs. 2016 May 16;39(3):136-40. doi: 10.5301/ijao.5000489. Epub 2016 Apr 14.
6
Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation.早期再灌注期间白细胞介素-8的释放可预测人类肺移植中的移植物功能。
Am J Respir Crit Care Med. 2002 Jan 15;165(2):211-5. doi: 10.1164/ajrccm.165.2.2011151.
7
Early release of proinflammatory cytokines after lung transplantation.肺移植后促炎细胞因子的早期释放。
Chest. 1998 Mar;113(3):645-51. doi: 10.1378/chest.113.3.645.
8
Interleukin-6, a marker of preservation injury in clinical lung transplantation.白细胞介素-6，临床肺移植中保存损伤的标志物。
J Heart Lung Transplant. 1992 Nov-Dec;11(6):1017-24.